Oncology Drugs Flashcards
Antimetabolites blocking Nucleotide synthesis
Azathioprine Cladribine Cytarabine 5-FU Hydroxyurea Methotrexate 6-MP
Topoisomerase inhibitors (S-G2)
Etoposide
Teniposide
Irinotecan
Topotecan
Impairing the double check repair (G2)
Bleomycin
Microtubule inhibitors (M phase)
Paclitaxel
Vinblastine
Vincristine
Colchicine (used for gout)
Cell cycle-independent drugs
Platinum agents (cisplatin) Alkylating agents: Busulfan Cyclophosphamide Ifosfamide Nitrosoureas (carmustine)
Azathioprine & 6-mercatopurine
Mech: Activated by HGPRT. Decrease de novo purine synthesis. Metabolized into 6-MP.
Use: Preventing organ rejection, RA, IBD, SLE, wean patients of steroids
Side Effects: Myelosuppression, GI and Liver. Metabolized by xanthine oxidase and increase in toxicity with allopurinol or febuxostat use in conjugation.
Cladribine
Mech: Purine analog with multiple mechanisms.
Use: Hairy Cell Leukemia
Side Effects: Nyelosuppression, Nephro- and Neurotoxicity.
Cytarabine (arabinofuranosyl cytidine)
Mech: Pyrimidine analog - blocks DNA polymerase
Use: Leukemias (AML), lymphomas
SE: Myelosuppression & megaloblastic anemia. CYTarabine causes panCTYopenia.
5-FU
Mech: Pyrimidine analog bioactivated to 5-FdUMP, which covalently complexes with thymidylate synthase and folic acid. Capecitabine has similar activity. This complex inhibits thymidylate synthase ↓dTMP→↓DNA synthesis
Use: Colon, pancreatic cancer and BCC (topically) EFFECT ARE ENHANCED w/ LEUCOVORIN
SE: Myelosuppresions, palmar-plantar erythrodysesthesia (hand-foot syndrome)
Methotrexate
Mech: Folic acid analog which competitively inhibits DHF reductase→↓dTMP→↓DNA synthesis
Use: Cancer: Leukemias (ALL), lymphomas, choriocarcinoma, sarcomas. Non-neoplastic: ectopic pregnancy, abortion (with misoprostol), rheumatoid arthritis, psoriasis, IBD, vasculitis
SE: Myelosuppresion, which is REVERSIBLE IF GIVEN LEUCOVORIN (rescue drug). Hepatotoxicity, Mucositis, Pulmonary fibrosis